Introduction {#S1}
============

There is general agreement in the literature that posture control and voice are related [@R01]^-^[@R03]; in fact, it has been demonstrated that correct posture is fundamental for quality function of the voice [@R04]^-^[@R12]. Voice disorders are usually associated with alterations in extra-laryngeal muscle activity, whereas changes in posture can sometimes have a significant role in the genesis and/or maintenance of these voice disorders, in a sort of vicious circle where a change in extra-laryngeal tension and an inadequate activity of the larynx itself contributes to and influences each other [@R13].

In recent years, the use of stabilometry for studying posture has permitted overcoming the many limits given by clinical tests alone [@R03] [@R11]^-^[@R14]. Computerised posturographic studies performed with a stabilometric platform supply extremely sensitive numeric parameters in subjects with purely dysfunctional dysphonia or dysphonia associated with secondary organic disorders, and even in subjects with no primary balance problems. Moreover, using static stabilometry in open-eye, closed-eye and in closed-eye with head backwards, the importance of the individual sensorial inputs (visual, vestibular and cervical proprioceptive) can be assessed, and when the test is performed during natural breathing (not forced) it is possible to study the prevalently reflex component of posture (spinal vestibular reflex: SVR) [@R13]. In fact, the systems controlling posture, balance and organisation of body movement rely principally on the integration of specific sensorial patterns for their function, followed by the elaboration of specific motor responses that are mainly reflex ones (the most important of which is undoubtedly the SVR).

Our recent studies on subjects with pure dysfunctional dysphonia show how the greater proprioception achieved through speech rehabilitation brings an improvement in the majority of the postural parameters evaluated with static stabilometry [@R13]. Our studies confirmed what was previously described in the relevant literature.[@R03] One of these studies evaluated postural variations in a group of subjects with dysfunctional dysphonia, and then compared these variations with the modifications seen in the stabilometric parameters after speech therapy [@R13]. The results obtained were very encouraging and call attention not only to the importance of stabilometric analysis in subjects with voice disorders associated with postural changes, but also to the fundamental role rehabilitation plays when resolving dysphonia and at the same time improving postural performance. With this in mind, investigation of the postural characteristics of patients with voice disorders who have organic lesions in the vocal folds appears interesting. We therefore submitted subjects with organic dysphonia due to acquired, benign vocal fold lesions to posturographic analysis, performing static stabilometry before and after phonomicrosurgery. Our aim was to understand if there were any postural characteristics particular to the individual organic disorders and to assess if removal of the lesion with phonomicrosurgery is, on its own, sufficient to modify the postural performance of subjects.

Materials and methods {#S2}
=====================

In this study, we assessed 40 patients (22 males and 18 females; mean age 32.6 ± 7.5 years) with organic dysphonia: 15 had a vocal fold polyp, 11 a submucosal retention cyst, 10 bilateral fibrous vocal fold nodules and 4 cases of bilateral Reinke\'s oedema. The clinical characteristics of patients are summarised in [Table I](#T1){ref-type="table"}. All subjects were submitted to a posturographic test using a static stabilometric platform (S.Ve.P. AMPLIFON-Amplaid, Milan, Italy), inviting patients to stand upright during the test and breathe normally. The test was carried out with the patients\' eyes both open (OE) and closed (CE) to eliminate visual afferents and enhance proprioceptive faculties. The posturographic test was carried out in basal conditions and then repeated 24 hours after phonosurgical removal of the vocal fold lesion. Moreover, the posturographic test was repeated at 6 months after surgery under the same conditions as the baseline and 24 hour control. The following parameters were considered: pressure centre coordinates on the frontal (X; right-left) (minimum X, maximum X, mean X) and sagittal (Y; forward/backward) (minimum Y, maximum Y, mean Y) areas; total length of the recording in mm (L); surface of the helix containing 90% of the points sampled (S); mean velocity (VEL) and relative SD; Fourier fast transform (FFT) for oscillations on the X and Y axes separately; statokinesigram describing the area within which the centre of gravity projects with respect to the floor, and stabilogram which reveals the time taken for the pressure centre to shift on both the X and Y axes.

###### 

Clinical characteristics of the study group.

  -------------------------------------------------------------------------------------------------------
  Study Group         Patients\       Sex (M/F)\   Age (yrs)\   LPR[^\*^](#T1FN1){ref-type="table-fn"}\
                      n = 40          22M/18F      32.6 ± 7.5   NO
  ------------------- --------------- ------------ ------------ -----------------------------------------
  Subgroups           Patients        Sex (M/F)    Age (yrs)    LPR[^\*^](#T1FN1){ref-type="table-fn"}

  Polyps              n = 15\         10M/5F       29.9 ± 6.4   NO
                      15/40 (37.5%)                             

  Acquired cysts      n = 11\         7M/4F        32.1 ± 7.3   NO
                      11/40 (27.5%)                             

  Bilateral nodules   n = 10\         2M/8F        33.3 ± 6.6   NO
                      10/40 (25%)                               

  Reinke\'s oedema    n = 4\          3M/1F        42.8 ± 7.4   NO
                      4/40 (10%)                                
  -------------------------------------------------------------------------------------------------------

LPR = Signs of laryngopharyngeal reflux

Each patient underwent accurate phoniatric and otorhinolaryngoiatric anamnesis, general ENT examination, flexible fiberoptic rhino-pharyngo-laryngoscopy, videolaryngostroboscopy, electro-acoustic voice tests including spectrography and analysis of the vocal signal with the multidimensional voice program (MDVP). Vocal signal was acquired by asking the patient to pronounce a sustained \[a\] vowel. All patients had been suffering from chronic dysphonia for at least six months and diagnosis of organic lesion of the vocal fold was made for at least three months in all study subjects.

All patients remarked that their voice disorder limited their social or working life. The subjective degree of severity of the condition was evaluated using the Voice Handicap Index (VHI) questionnaire, which each patient filled in before surgical treatment [@R15]. The perceptive evaluation of voice was scored against the GRBAS Scale[@R16]. The acoustic analysis, perceptual analysis and patient\'s self-assessment were performed before and 6 months after surgery.

The tests carried out with flexible fiberoptic endoscopy and rigid videolaryngostroboscopy (70°) revealed organic damage in the glottic plane of all the subjects in the study. None of the patients showed signs of posterior inflammation due to laryngo-pharyngeal reflux, whereas they all showed some degree of tentative compensation by the supraglottic structures to aid closure of the glottis during phonation, since closure was faulty because of the organic lesion on the vocal fold. In the 5 cases with submucosal cyst, stroboscopic light revealed an interruption of mucosal wave on the site of the lesion.

After accurate anamnesis and orthopaedic examination, all patients with orthopaedic disorders or known postural defects (varus/valgus foot, scoliosis, previous orthopaedic surgery of any kind, etc.) were excluded from the study. Additionally, those who showed balance disorders during anamnesis and/or were classified positive upon otoneurological examination were excluded from the study. To evaluate the possible presence of oto-neurological diseases, the following tests were performed: accurate oto-neurological assessment, liminal tonal audiometry, investigation of spontaneous and provoked nystagmus by videonystagmography and vestibular caloric balance. Other exclusion criteria were systemic disease, alcohol abuse, psychiatric disorder and vision less than 10/10.

Seven subjects were excluded from the study: 3 cases were affected by oto-neurological diseases (1 case of Menière\'s disease, 1 case of recurrent paroxysmal positional vertigo and 1 case of recent vestibular neuronitis), 2 cases were affected by scoliosis, 1 case was affected by whiplash injury with functional limitation of the cervical spine, while 1 case was affected by diabetes mellitus type I. Therefore, considering the inclusion and exclusion criteria, 40 subjects were included in the study group.

None of the patients had undergone previous speech rehabilitation/ therapy. Even the 10 patients with fibrous nodules had never been submitted to rehabilitation treatment since, at diagnosis, patients chose surgical treatment after all therapeutic options had been explained to them.

After surgical treatment, the study group was not submitted to speech therapy either because it was not advisable or because the patients refused it.

Surgical treatment {#S2a}
------------------

The phonomicrosurgery procedure was performed under general anaesthesia using specific instruments for endolaryngeal phonosurgery and according to the methods described in the national and international literature [@R17] [@R18].

Statistical analysis {#S2b}
--------------------

All numeric parameters are expressed in medians. A comparison was performed between several parameters at different times, before and after surgical treatment. The comparison (before open-eye *vs* after open-eye mode; before closed-eye vs after closed-eye mode; after 24 h *vs* after 6 months surgery) was carried out considering the median of the different parameters with a Wilcoxon nonparametric test and considering the same parameters for the percentage of pathological patients using a chi^2^ Test. The parameters resulting above normal range with this instrument were considered pathological. All tests were considered significant with p \< 0.05. StatView 5 release 5.0.1 was used to process data.

Results {#S3}
=======

Control laryngostroboscopy carried out at one month and 6 months after phonomicrosurgery demonstrated the absence of organic lesions in all the subjects.

The results of acoustic analysis (MDVP), perceptual analysis (GRBAS) and VHI performed before and 6 months after surgical treatment are summarised in [Tables II](#T2){ref-type="table"}, [III](#T3){ref-type="table"} and [IV](#T4){ref-type="table"}.

###### 

Results of the acoustic analysis (MDVP) for Jitter %, Shimmer %, NHR and SPI parameters, before and 6 months after phonomicrosurgery.

  ---------------------- -------------- -------------- -----------
  **POLYPS**                                           
                         **Pre**        **Post**       **p**
  Jitter %               2.23 ± 0.32    0.31 ± 0.36    p \< 0.01
  Shimmer %              3.34 ± 0.82    1.92 ± 0.71    
  NHR                    0.14 ± 0.12    0.09 ± 0.06    
  SPI                    26.43 ± 4.24   8.11 ± 4.13    
  **NODULES**                                          
                         **Pre**        **Post**       **p**
  Jitter %               1.73 ± 0.21    0.91 ± 0.22    p \< 0.01
  Shimmer %              4.15 ± 0.84    2.13 ± 0.41    
  NHR                    0.12 ± 0.02    0.06 ± 0.02    
  SPI                    16.36 ± 3.83   4.92 ± 1.63    
  **CYSTS**                                            
                         **Pre**        **Post**       **p**
  Jitter %               1.97 ± 0.44    0.52 ± 0.31    p \< 0.01
  Shimmer %              5.26 ± 0.85    0.33 ± 0.01    
  NHR                    0.18 ± 0.31    0.08 ± 0.06    
  SPI                    16.94 ± 3.93   11.12 ± 1.63   
  **REINKE\'S OEDEMA**                                 
                         **Pre**        **Post**       **p**
  Jitter %               4.55 ± 1.25    1.23 ± 0.61    p \< 0.01
  Shimmer %              11.46 ± 3.23   3.82 ± 1.31    
  NHR                    0.25 ± 0.14    0.12 ± 0.04    
  SPI                    12.86 ± 3.67   6.25 ± 1.24    
  ---------------------- -------------- -------------- -----------

###### 

Results of patient self-assessment (VHI), before and 6 months after phonomicrosurgery.

                     Pre                   Post                 p
  ------------------ --------------------- -------------------- -------------
  Polyps             37.2 ± 16.6 (18-73)   9.3 ± 3.2 (4-14)     p \< 0.0001
  Nodules            32.1 ± 12.5 (15-56)   11.8 ± 5.3 (4-19)    p \< 0.001
  Cysts              41.5 ± 15.9 (22-71)   10.9 ± 4.9 (3-20)    p \< 0.0001
  Reinke\'s oedema   33.3 ± 6.7 (27-40)    16.8 ± 2.8 (14-20)   p = 0.004
  Total (N = 40)     36.7 ± 14.7 (15-73)   11.1 ± 4.5 (3-20)    p \< 0.0001

###### 

Results of the perceptual analysis (GRBAS) before and 6 months after phonomicrosurgery.

  ---------------------- ----------- ----------- -------------
  **POLYPS**                                     
                         **Pre**     **Post**    **p**
  G                      1.7 ± 0.6   0.2 ± 0.3   p \< 0.0001
  R                      1.2 ± 0.5   0.1 ± 0.2   
  B                      1.4 ± 0.6   0.1 ± 0.2   
  A                      0.9 ± 0.3   0.1 ± 0.2   
  S                      0.7 ± 0.6   0.2 ± 0.3   p = 0.04
  **NODULES**                                    
                         **Pre**     **Post**    **p**
  G                      1.4 ± 0.4   0.2 ± 0.3   p \< 0.001
  R                      1.2 ± 0.3   0.1 ± 0.1   
  B                      1.7 ± 0.6   0.2 ± 0.2   
  A                      1.1 ± 0.8   0.2 ± 0.4   
  S                      1.4 ± 0.6   0.2 ± 0.2   
  **CYSTS**                                      
                         **Pre**     **Post**    **p**
  G                      1.9 ± 0.8   0.3 ± 0.4   p \< 0.001
  R                      1.5 ± 0.7   0.3 ± 0.5   
  B                      1.6 ± 0.6   0.2 ± 0.2   
  A                      1.2 ± 0.4   0.1 ± 0.2   
  S                      1.1 ± 0.8   0.2 ± 0.2   
  **REINKE\'S OEDEMA**                           
                         **Pre**     **Post**    **p**
  G                      1.9 ± 0.7   0.4 ± 0.1   p \< 0.005
  R                      2.0 ± 0.5   0.5 ± 0.5   
  B                      0.6 ± 0.1   0.2 ± 0.2   NS
  A                      1.2 ± 0.5   0.3 ± 0.1   p \< 0.005
  S                      1.5 ± 0.6   0.3 ± 0.2   
  ---------------------- ----------- ----------- -------------

Stabilometric study {#S3a}
-------------------

### Basal conditions (Pre-OE and Pre-CE) {#S3aa}

In basal conditions (before phonomicrosurgery), no characteristic pathological stabilometric pattern was seen within the individual groups (polyps, cysts and Reinke\'s oedema). An anterior shift from the centre of gravity was seen in 8 of 10 patients with fibrous vocal nodules (80%) in both open-eye and closed-eye tests. Such an anterior shift from the centre of gravity was evident at analysis of the posturographic trace and, in particular, of the statokinesigram.

### Pre-OE vs Post-OE1 and Pre-CE vs Post-CE1 (Follow-up at 24 h) and Pre-OE vs Post-OE2 and Pre-CE vs Post- CE2 (follow-up at 6 months) {#S3ab}

A comparison performed within the individual groups (polyps, nodules, cysts and Reinke\'s oedema) before and after surgery (after 24 hours and after 6 months) in open-eye (Pre-OE *vs* Post-OE1; Pre-OE *vs* Post-OE2) and closed-eye manner (Pre-CE *vs* Post-CE1; Pre-CE *vs* Post- CE2) showed that there were no statistically significant differences in any of the parameters studied. Even the stabilometric tests performed after surgery in the 10 subjects with vocal nodules detected no shifts from the centre of gravity and showed no substantial modifications compared to basal conditions in the parameters studied.

### Post-OE1 (24h) vs Post-OE2 (6 months) and Post-CE1 (24h) vs Post-CE2 (6 months) {#S3ac}

A comparison performed within the individual groups after surgery (24h) vs follow-up (6 months) in open-eye (Post-OE1 *vs* Post-OE2) and closed-eye manner (Post- CE1 *vs* Post-CE2) showed that there were no statistically significant differences in any of the parameters studied.

The results are summarised for each subgroup in [Tables V](#T5){ref-type="table"} and [VI](#T6){ref-type="table"}.

###### 

Pre-OE, Post-OE1 (after 24h), Post-OE2 (after 6 months): values of each parameter in the *open-eye* mode study, before and after phonomicrosurgery (median). Pre-OE N (%), Post-OE1 (after 24h) and Post-OE2 (after 6 months) N (%): number of pathological patients and the relative percentage for each parameter. p1: statistical significance of the pre- vs post-therapy comparison referring to the median (Wilcoxon). p2: statistical significance of the pre- vs post-therapy comparison referring to the number of pathological patients (Chi^2^).

  ------------------------------ ------------- -------------- -------------- -------- ------------------- --------------------- --------------------- --------
  **POLYPS (N = 15)**                                                                                                                                 
                                 **Pre-OE**    **Post-OE1**   **Post-OE2**   **p1**   **Pre-OE N° (%)**   **Post-OE1 N° (%)**   **Post-OE2 N° (%)**   **p2**
  Xmin                           -9.89         -8.56          -10.1          NS       1 (6%)              2 (12%)               1 (6%)                NS
  Xmax                           5.21          3.49           4.24           NS       2 (12%)             1 (6%)                1 (6%)                NS
  Xmed                           -2.89         -3.28          -2.48          NS       1 (6%)              1 (6%)                1 (6%)                NS
  SD (X)                         0.23          0.22           0.24           NS       \-                  \-                    \-                    \-
  Ymin                           -34.62        -30.57         -33.61         NS       1 (6%)              0                     0                     NS
  Ymax                           -29.67        -27.93         -30.35         NS       0                   0                     0                     NS
  Ymed                           -32.59        -34.51         -32.81         NS       0                   0                     0                     \-
  SD (Y)                         0.29          0.27           0.32           NS       \-                  \-                    \-                    NS
  L                              194.45        201.56         203.39         NS       1 (6%)              1 (6%)                0                     NS
  S                              141.78        135.69         138.93         NS       2 (12%)             2 (12%)               2 (12%)               NS
  FFTx                           0.04          0.04           0.04           NS       \-                  \-                    \-                    \-
  FFTy                           0.08          0.04           0.04           NS       \-                  \-                    \-                    \-
  VEL                            12.44         11.35          13.82          NS       \-                  \-                    \-                    \-
  SD(VEL)                        4.43          4.09           4.93           NS       3 (18%)             2 (12%)               2 (12%)               NS
  **NODULES (N = 10)**                                                                                                                                
                                 **Pre-OE**    **Post-OE1**   **Post-OE2**   **p1**   **Pre-OE N°(%)**    **Post-OE1 N°(%)**    **Post-OE2 N°(%)**    **p2**
  Xmin                           -9.79         -9.54          -10.56         NS       2 (20%)             2 (20%)               1 (10%)               NS
  Xmax                           4,11          3.82           5.34           NS       1 (10%)             1 (10%)               1 (10%)               NS
  Xmed                           -1.39         -1.03          -2.62          NS       1 (10%)             1 (10%)               1 (10%)               NS
  SD (X)                         0.26          0.24           0.22           NS       \-                  \-                    \-                    \-
  Ymin                           -57.52        -55.31         -52.83         NS       1 (10%)             1 (10%)               1 (10%)               NS
  Ymax                           -38.02        -34.80         -36.81         NS       2 (20%)             2 (20%)               2 (20%)               NS
  Ymed                           -47.34        -45.59         -44.21         NS       1 (10%)             1 (10%)               2 (20%)               \-
  SD (Y)                         0.32          0.30           0.30           NS       \-                  \-                    \-                    NS
  L                              252.36        248.81         261.78         NS       1 (10%)             1 (10%)               1 (10%)               NS
  S                              150.12        148.9          154.87         NS       3 (30%)             3 (30%)               3 (30%)               NS
  FFTx                           0.08          0.08           0.08           NS       \-                  \-                    \-                    \-
  FFTy                           0.08          0.08           0.08           NS       \-                  \-                    \-                    \-
  VEL                            11.65         11.92          13.03          NS       \-                  \-                    \-                    \-
  SD(VEL)                        11.33         10.52          11.04          NS       4 (40%)             3 (30%)               3 (30%)               NS
  **CYSTS (N = 11)**                                                                                                                                  
                                 **Pre-OE**    **Post-OE1**   **Post-OE2**   **p1**   **Pre-OE N°(%)**    **Post-OE1 N°(%)**    **Post-OE2 N°(%)**    **p2**
  Xmin                           2.44          3.69           4.35           NS       1 (9%)              1 (9%)                0                     NS
  Xmax                           12.69         14.82          16.92          NS       2 (18%)             1 (9%)                1 (9%)                NS
  Xmed                           8.51          6.91           8.34           NS       1 (9%)              1 (9%)                1 (9%)                NS
  SD (X)                         0.30          0.29           0.24           NS       \-                  \-                    \-                    \-
  Ymin                           -49.50        -44.30         -51.91         NS       0                   0                     0                     NS
  Ymax                           -31.39        -38.31         -43.72         NS       1 (9%)              2 (18%)               1 (9%)                NS
  Ymed                           -40.49        -41.08         -44.45         NS       0                   0                     0                     \-
  SD (Y)                         0.33          0.31           0.30           NS       \-                  \-                    \-                    NS
  L                              229.31        212.83         259.93         NS       1 (9%)              1 (9%)                1 (9%)                NS
  S                              132.28        149.72         151.78         NS       2 (18%)             1 (9%)                2 (18%)               NS
  FFTx                           0.04          0.06           0.08           NS       \-                  \-                    \-                    \-
  FFTy                           0.04          0.04           0.04           NS       \-                  \-                    \-                    \-
  VEL                            11.56         12.83          13.35          NS       \-                  \-                    \-                    \-
  SD(VEL)                        6.89          7.31           5.21           NS       2 (18%)             2 (18%)               1 (9%)                NS
  **REINKE\'S OEDEMA (N = 4)**                                                                                                                        
                                 **Pre-OE1**   **Post-OE1**   **Post-OE2**   **p1**   **Pre-OE N° (%)**   **Post-OE1 N° (%)**   **Post-OE2 N° (%)**   **p2**
  Xmin                           -6.32         -7.02          -9.23          NS       0                   0                     0                     NS
  Xmax                           3.68          2.07           4.45           NS       0                   0                     0                     NS
  Xmed                           -1.02         -2.82          -3.69          NS       1 (25%)             1 (25%)               0                     NS
  SD (X)                         0.20          0.22           0.20           NS       \-                  \-                    \-                    \-
  Ymin                           -51.2         -50.79         -59.38         NS       1 (25%)             1 (25%)               1 (25%)               NS
  Ymax                           -31.30        -26.89         -26.51         NS       0                   0                     0                     NS
  Ymed                           -45.19        -41.79         -49.42         NS       0                   0                     0                     \-
  SD (Y)                         0.39          0.37           0.35           NS       \-                  \-                    \-                    NS
  L                              239.06        230.92         221.38         NS       1 (25%)             1 (25%)               \-                    NS
  S                              108.72        121.28         118.92         NS       0                   0                     0                     NS
  FFTx                           0.04          0.04           0.04           NS       \-                  \-                    \-                    \-
  FFTy                           0.04          0.04           0.04           NS       \-                  \-                    \-                    \-
  VEL                            11.44         10.72          15.59          NS       \-                  \-                    \-                    \-
  SD(VEL)                        7.37          6.81           8.12           NS       2 (50%)             2 (50%)               1 (25%)               NS
  ------------------------------ ------------- -------------- -------------- -------- ------------------- --------------------- --------------------- --------

###### 

Pre- and Post- therapy values considering the above parameters in the closed-eye mode (CE).

  ------------------------------ ------------ -------------- -------------- -------- ------------------- --------------------- --------------------- --------
  **POLYPS (N=15)**                                                                                                                                  
                                 **Pre-CE**   **Post-CE1**   **Post-CE2**   **p1**   **Pre-CE N°(%)**    **Post-CE1 N°(%)**    **Post-CE2 N°(%)**    **p2**
  Xmin                           -14.25       -12.97         -10.12         NS       1 (6%)              1 (6%)                0                     NS
  Xmax                           7.29         6.92           12.56          NS       2 (12%)             2 (12%)               1 (6%)                NS
  Xmed                           -4.38        -3.83          -1.98          NS       1 (6%)              1 (6%)                2 (12%)               NS
  SD (X)                         0.30         0.28           0.35           NS       \-                  \-                    \-                    \-
  Ymin                           -47.49       -45.41         -54.36         NS       1 (6%)              1 (6%)                1 (6%)                NS
  Ymax                           -41.31       -40.29         -48.05         NS       1 (6%)              1 (6%)                1 (6%)                NS
  Ymed                           -45.21       -40.49         -52.79         NS       0                   0                     0                     \-
  SD (Y)                         0.30         0.29           0.30           NS       \-                  \-                    \-                    NS
  L                              403.38       383.549        409.93         NS       2 (12%)             2 (12%)               2 (12%)               NS
  S                              326.45       319.38         312.57         NS       2 (12%)             1 (6%)                1 (6%)                NS
  FFTx                           0.04         0.04           0.04           NS       \-                  \-                    \-                    \-
  FFTy                           0.08         0.08           0.06           NS       \-                  \-                    \-                    \-
  VEL                            15.36        14.85          18.45          NS       \-                  \-                    \-                    \-
  SD(VEL)                        9.45         8.87           10.45          NS       3 (18%)             3 (18%)               2 (12%)               NS
  **NODULES (N=10)**                                                                                                                                 
                                 **Pre-CE**   **Post-CE1**   **Post-CE2**   **p1**   **Pre-CE N°(%)**    **Post-CE1 N°(%)**    **Post-CE2 N°(%)**    **p2**
  Xmin                           -16.78       -15.38         -17.45         NS       1 (10%)             2 (20%)               2 (20%)               NS
  Xmax                           8.31         7.46           9.69           NS       2 (20%)             1 (10%)               2 (20%)               NS
  Xmed                           -5.38        -4.13          -6.38          NS       2 (20%)             2 (20%)               2 (20%)               NS
  SD (X)                         0.40         0.38           0.40           NS       \-                  \-                    \-                    \-
  Ymin                           -63.34       -60.34         65.91          NS       2 (20%)             2 (20%)               2 (20%)               NS
  Ymax                           -45.29       -40.39         -50.23         NS       2 (20%)             2 (20%)               2 (20%)               NS
  Ymed                           -54.82       -53.78         -49.36         NS       2 (20%)             2 (20%)               3 (30%)               \-
  SD (Y)                         0.40         0.41           0.40           NS       \-                  \-                    \-                    NS
  L                              503.26       482.29         492.91         NS       2 (20%)             2 (20%)               2 (20%)               NS
  S                              327.12       303.92         336.43         NS       3 (30%)             3 (30%)               3 (30%)               NS
  FFTx                           0.08         0.08           0.08           NS       \-                  \-                    \-                    \-
  FFTy                           0.08         0.08           0.06           NS       \-                  \-                    \-                    \-
  VEL                            16.23        14.38          16.36          NS       \-                  \-                    \-                    \-
  SD(VEL)                        11.36        10.38          12.65          NS       5 (50%)             4 (40%)               4 (40%)               NS
  **CYSTS (N = 11)**                                                                                                                                 
                                 **Pre-CE**   **Post-CE1**   **Post-CE2**   **p1**   **Pre-CE N° (%)**   **Post-CE1 N° (%)**   **Post-CE2 N° (%)**   **p2**
  Xmin                           -4.28        -2.89          -4.35          NS       2 (18%)             1 (9%)                2 (18%)               NS
  Xmax                           14.3         11.29          9.13           NS       2 (18%)             1 (9%)                1 (9%)                NS
  Xmed                           6.16         5.29           3.69           NS       1 (9%)              1 (9%)                1 (9%)                NS
  SD (X)                         0.25         0.26           0.28           NS       \-                  \-                    \-                    \-
  Ymin                           -72.38       -70.31         -65.5          NS       0                   0                     0                     NS
  Ymax                           -50.39       -48.34         -49.1          NS       2 (18%)             2 (18%)               2 (18%)               NS
  Ymed                           -62.14       -59.29         -57.49         NS       1 (9%)              1 (9%)                1 (9%)                \-
  SD (Y)                         0.42         0.40           0.36           NS       \-                  \-                    \-                    NS
  L                              501.34       490.29         505.39         NS       1 (9%)              1 (9%)                1 (9%)                NS
  S                              298.56       257.82         282.31         NS       2 (18%)             1 (9%)                2 (18%)               NS
  FFTx                           0.04         0.04           0.04           NS       \-                  \-                    \-                    \-
  FFTy                           0.04         0.04           0.03           NS       \-                  \-                    \-                    \-
  VEL                            12.76        12.08          12.23          NS       \-                  \-                    \-                    \-
  SD(VEL)                        10.89        11,31          11.41          NS       2 (18%)             2 (18%)               2 (18%)               NS
  **REINKE\'S OEDEMA (N = 4)**                                                                                                                       
                                 **Pre-CE**   **Post-CE1**   **Post-CE2**   **p1**   **Pre-CE N° (%)**   **Post-CE1 N° (%)**   **Post-CE2 N° (%)**   **p2**
  Xmin                           -11.91       -10.93         -10.6          NS       0                   0                     0                     NS
  Xmax                           19.18        18.92          15.19          NS       0                   0                     0                     NS
  Xmed                           -0.48        1.39           1.21           NS       1 (25%)             1( 25%)               1 (25%)               NS
  SD (X)                         0.45         0.41           0.36           NS       \-                  \-                    \-                    \-
  Ymin                           -77.74       -74.92         -70.76         NS       1 (25%)             1 (25%)               1 (25%)               NS
  Ymax                           -26.40       -25.93         -32.98         NS       0                   0                     1 (25%)               NS
  Ymed                           -42.98       -40.38         -49.39         NS       0                   0                     0                     \-
  SD (Y)                         0.70         0.66           0.54           NS       \-                  \-                    \-                    NS
  L                              612.27       603.38         598.49         NS       1 (25%)             1 (25%)               1 (25%)               NS
  S                              321.78       355.98         343.05         NS       0                   0                     0                     NS
  FFTx                           0.12         0.12           0.14           NS       \-                  \-                    \-                    \-
  FFTy                           0.12         0.12           0.12           NS       \-                  \-                    \-                    \-
  VEL                            23.27        22.79          19.49          NS       \-                  \-                    \-                    \-
  SD(VEL)                        11.41        10.96          10.62          NS       2 (50%)             2 (50%)               2 (50%)               NS
  ------------------------------ ------------ -------------- -------------- -------- ------------------- --------------------- --------------------- --------

Discussion {#S4}
==========

It is now acknowledged that pure dysfunctional dysphonia or the types associated with secondary larynx disorders (with vocal fold lesions) are related to modified respiratory dynamics and particular postural characteristics [@R19]. Thanks to computerised posturographic studies, it is now possible to accurately evaluate the numerical parameters and graphics that reflect even the slightest modification in posture. In fact, static stabilometry performed in basal conditions has been able to reveal postural modifications associated with voice disorders, which showed significant variations in the stabilometric parameters after speech rehabilitation [@R03] [@R13]. On the other hand, there are no studies aimed at discovering whether these postural alterations are present even in cases of organic dysphonia and if removal of the lesion through phonomicrosurgery can, on its own, bring about substantial changes in postural performance. Hence, we submitted a heterogeneous group of patients with organic dysphonia (vocal fold polyps, nodules, acquired submucosal cysts and Reinke\'s oedema) to static stabilometry to see if there were any postural characteristics that were typical to the individual organic disorder, and to assess if phonomicrosurgery alone is sufficient to modify the posture of patients.

In basal conditions, none of the subgroups studied (polyps, cysts and Reinke\'s oedema) showed any characteristic pathological stabilometric pattern. In fact, the majority of parameters were within the normal range, with no significant deviations from the centre of gravity. Only eight patients (8/10; 80%) in the subgroup with bilateral nodules on the vocal folds showed a forward shift from the centre of gravity, and pathological S and SD VEL values both in open-eye and closed-eye conditions, attesting the postural characteristics of subjects with pure dysfunctional dysphonia [@R13]. This confirms what has already been acknowledged; that is, vocal fold nodules may be, at least in some cases, the direct consequence of long-standing dysfunctional dysphonia that has been inadequately treated. Hence, patients with vocal fold nodules display a stabilometric pattern both in the open-eye and closed-eye examinations that is similar to what is seen in patients with pure dysfunctional dysphonia; on the contrary, however, the parameters of the former subjects do not improve significantly at 24 hours after surgery. While the majority of the stabilometric parameters improve significantly in subjects with pure dysfunctional dysphonia after rehabilitation therapy [@R03] [@R13], the group with vocal fold nodules continue to have modified posture at 24 hours and 6 months after phonosurgery and manifest no significant variations. From a postural point of view, this fact indirectly confirms the importance of giving adequate and sufficiently lengthy rehabilitation treatment to patients with dysfunctional dysphonia associated with altered posture. On the other hand, the static stabilometric results obtained both in basal conditions and after phonomicrosurgery in cases of polyps, cysts and Reinke\'s oedema demonstrate how modified postural performance in these circumstances is much less pronounced and not so distinctive. One would assume that, immediately after surgery, the situation remains the same as before, while a longer follow-up can show some changes in postural control, related to voice amelioration. The follow-up at 6 months contradicts this hypothesis: in fact, the stabilometric parameters 6 months after surgery do not change in a statistically significant way as formerly observed at 24 hours after surgery ([Fig. 1](#F1){ref-type="fig"}).

![Stabilometric finding (statokinesigram) of a patient with submucosal retention cyst in the closed-eye mode in basal conditions (A), 24 h after phonomicrosurgery (B) and 6 months after surgery (C). No characteristic pathological pattern was seen in basal conditions; a comparison performed before and after surgery (after 24h and after 6 months), revealed no significant difference in the statokinesigram pattern.](0392-100X-37-286-g001){#F1}

Conclusions {#S5}
===========

Thanks to static stabilometry it is possible to define the absence of postural alterations in subjects with organic disorders on the glottis plane that are not secondary to problems of a dysfunctional nature. Moreover, this study demonstrates how simple surgical removal of the vocal fold lesion does lead to modification of posture.

In spite of the fact that the results obtained refer to an extremely heterogeneous group, from both a pathophysiological and a clinical point of view, and that the statistical analysis was performed on a restricted number of subjects within each individual subgroup, it is important to again stress how important it is to submit dysphonic subjects with no signs of vertigo to stabilometric analysis.

This study is in line with what has been reported in previous studies [@R03] [@R13], namely, that skilfully performed speech rehabilitation therapy is fundamental for correcting both voice disorders and altered posture in cases of dysfunctional dysphonia. The results obtained in this study will have to be confirmed in the future, taking into account a larger patient population and a lengthier follow-up.
